153 related articles for article (PubMed ID: 34959453)
1. Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats.
Karbownik A; Szkutnik-Fiedler D; Grabowski T; Wolc A; Stanisławiak-Rudowicz J; Jaźwiec R; Grześkowiak E; Szałek E
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959453
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of potential for UGT-inhibition-based drug-drug interaction between sorafenib and tapentadol.
Karbownik A; Miedziaszczyk M; Grabowski T; Stanisławiak-Rudowicz J; Jaźwiec R; Wolc A; Grześkowiak E; Szałek E
Biomed Pharmacother; 2020 Oct; 130():110530. PubMed ID: 32712531
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats.
Karbownik A; Szkutnik-Fiedler D; Czyrski A; Kostewicz N; Kaczmarska P; Bekier M; Stanisławiak-Rudowicz J; Karaźniewicz-Łada M; Wolc A; Główka F; Grześkowiak E; Szałek E
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605304
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
[TBL] [Abstract][Full Text] [Related]
6. In vivo assessment of the drug interaction between sorafenib and paracetamol in rats.
Karbownik A; Sobańska K; Grabowski T; Stanisławiak-Rudowicz J; Wolc A; Grześkowiak E; Szałek E
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1039-1048. PubMed ID: 32394097
[TBL] [Abstract][Full Text] [Related]
7. The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats.
Karbownik A; Stachowiak A; Urjasz H; Sobańska K; Szczecińska A; Grabowski T; Stanisławiak-Rudowicz J; Wolc A; Grześkowiak E; Szałek E
Pharmacol Rep; 2020 Feb; 72(1):254-259. PubMed ID: 32016844
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between regorafenib and atorvastatin in rats.
Szkutnik-Fiedler D; Szałek E; Otto F; Czyrski A; Karaźniewicz-Łada M; Wolc A; Grześkowiak E; Lewandowski K; Karbownik A
Pharmacol Rep; 2024 Apr; ():. PubMed ID: 38632186
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial.
Boinpally R; Spaventa J; Chen K; Butler M
Clin Drug Investig; 2021 Jun; 41(6):557-567. PubMed ID: 33948911
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice.
Karbownik A; Szałek E; Sobańska K; Grabowski T; Wolc A; Grześkowiak E
Eur J Pharm Sci; 2017 May; 102():55-62. PubMed ID: 28232141
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood-Brain Barrier in Rats.
Karbownik A; Stanisławiak-Rudowicz J; Stachowiak A; Romański M; Grześkowiak E; Szałek E
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):801-808. PubMed ID: 32776310
[TBL] [Abstract][Full Text] [Related]
12. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers.
Elmekawy HA; Belal F; Abdelaziz AE; Abdelkawy KS; Ali AA; Elbarbry F
Eur J Clin Pharmacol; 2021 Sep; 77(9):1369-1379. PubMed ID: 33791829
[TBL] [Abstract][Full Text] [Related]
15. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.
Drewe J; Ball HA; Beglinger C; Peng B; Kemmler A; Schächinger H; Haefeli WE
Br J Clin Pharmacol; 2000 Sep; 50(3):237-46. PubMed ID: 10971308
[TBL] [Abstract][Full Text] [Related]
16. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation.
Eckhardt K; Li S; Ammon S; Schänzle G; Mikus G; Eichelbaum M
Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
Patel P; Salapatek AM; Talluri RS; Tantry SK
Allergy Asthma Proc; 2018 May; 39(3):232-239. PubMed ID: 29669668
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
Cho HY; Yoon H; Lim YC; Lee YB
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
[TBL] [Abstract][Full Text] [Related]
19. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4.
Wang X; Zhang X; Huang X; Li Y; Wu M; Liu J
Xenobiotica; 2016 Jul; 46(7):651-658. PubMed ID: 26582036
[TBL] [Abstract][Full Text] [Related]
20. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
Wang LH; Chittick GE; McDowell JA
Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
